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Steroids are known to induce pleiotropic drug resistance states in hemiascomycetes, with tremendous
potential consequences for human fungal infections. Our analysis of gene expression in Saccharomyces cerevi-
siae and Candida albicans cells subjected to three different concentrations of progesterone revealed that their
pleiotropic drug resistance (PDR) networks were strikingly sensitive to steroids. In S. cerevisiae, 20 of the
Pdr1p/Pdr3p target genes, including PDR3 itself, were rapidly induced by progesterone, which mimics the
effects of PDR1 gain-of-function alleles. This unique property allowed us to decipher the respective roles of
Pdr1p and Pdr3p in PDR induction and to define functional modules among their target genes. Although the
expression profiles of the major PDR transporters encoding genes ScPDR5 and CaCDR1 were similar, the S.
cerevisiae global PDR response to progesterone was only partly conserved in C. albicans. In particular, the role
of Tac1p, the main C. albicans PDR regulator, in the progesterone response was apparently restricted to five
genes. These results suggest that the C. albicans and S. cerevisiae PDR networks, although sharing a conserved
core regarding the regulation of membrane properties, have different structures and properties. Additionally,
our data indicate that other as yet undiscovered regulators may second Tac1p in the C. albicans drug response.
Candida albicans is a commensal organism that colonizes a
large proportion of the population on the mucosal surfaces of
the gastrointestinal and urogenital tracts without clinical symp-
toms. But in immunocompromised patients, C. albicans causes
a wide spectrum of diseases ranging from mucocutaneous in-
fections like oral thrush to disseminated candidiasis, with a
mortality rate of 40% despite the use of available antifungal
agents (19). The various sites of Candida infection in the hu-
man body present different challenges, and the conditions
within the microenvironments that change the relationship of
C. albicans with the host from commensal to pathogenic need
to be studied in more detail. Recent efforts have revealed that
yeast cells can respond to human steroids (15, 27). Some in-
vestigators have determined the presence in yeast of steroid
binding proteins, such as estradiol binding protein (32), corti-
costeroid binding protein (33), and progesterone binding pro-
tein (12), but their exact role in the steroid response is not
known. Early and more recent studies have shown that steroids
can induce a pleiotropic drug resistance (PDR) state in both C.
albicans and Saccharomyces cerevisiae. This PDR state was
mediated by the overexpression of genes encoding PDR de-
terminants, such as the ABC transporter-encoding genes
CaCDR1, CaCDR2, and ScPDR5, which are known to be reg-
ulated by the CaTac1p, ScPdr1p, and ScPdr3p transcription
factors, respectively (11, 34). It is noteworthy that the CaTAC1
gene was itself found responsive to estradiol (9) and proges-
terone (this study). de Micheli et al. (15) investigated the
transcriptional basis of the steroid responsiveness of Candida
genes by analyzing the CDR1 promoter and identified a nucle-
otide stretch spanning 462 to 213 (with respect to ATG)
which mediates both drug and steroid responses (15). Al-
though belonging to the same family of Gal4-like zinc finger
proteins, Tac1p is not orthologous to Pdr1p and Pdr3p and has
less than 20% sequence identity with these proteins. As a
consequence, the DNA binding sites of Pdr1p and Pdr3p
(named PDRE [5-TCCGYGGR-3]) are significantly differ-
ent from the Tac1p recognition motif (named DRE [5-CGG
AA/TATCGGATA-3]) (15). Our own analysis of the CDR1
promoter led to the identification of two hitherto-unknown
cis-regulatory regions responding specifically to progesterone
and -estradiol and showed that other steroid-responsive
genes in the C. albicans genome also contain these sequences,
indicating a conserved role in mediating the steroid response in
C. albicans (5, 26). More recently it has been shown by tran-
scriptome analysis that the yeast responses to high doses of
progesterone involved a large number of both C. albicans and
S. cerevisiae genes (5, 6, 9).
In the present study, we aimed at deciphering a more accu-
rate evolutionary significance of the steroid response in yeasts
* Corresponding author. Mailing address for Rajendra Prasad:
Membrane Biology Laboratory, School of Life Sciences, Jawaharlal
Nehru University, New Delhi 110067, India. Phone: 91-11-26704509.
Fax: 91-11-26197338. E-mail: rp47@mail.jnu.ac.in. Mailing address for
Frederic Devaux: Laboratoire de Genetique Moleculaire, Ecole
Normale Superieure/CNRS UMR 8541, Paris 75005, France. Phone:
33 1 44 32 35 72. Fax: 33 1 44 32 39 41. E-mail: devaux@biologie.ens.fr.
† Supplemental material for this article may be found at http://ec
.asm.org/.
‡ Both authors contributed equally to this work.
 Published ahead of print on 9 November 2007.
68
by submitting S. cerevisiae and C. albicans cells to several doses
of progesterone for different time periods. The diploid C. al-
bicans evolved and diverged from the haploid S. cerevisiae
several million years ago. The question of the commonalities
and differences between the responses in the two species was
particularly intriguing. Indeed, C. albicans is a pathogenic fun-
gus which has to adapt to host defense and the relatively stable
yet location-specific human-body environments, whereas S.
cerevisiae, a free-living yeast, has to deal with the very variable
chemical and physical features of its environment. These yeast
species are also distinct in basal metabolism, which has impor-
tant implications for the structure and evolution of their tran-
scriptional networks (24).
We show here that the PDR pathway is the most sensitive to
progesterone in both species. Our data indicate that proges-
terone is very close to the optimal chemical signal that triggers
a rapid and stable PDR response in both pathogenic and non-
pathogenic yeasts. In the present work, we used this property
to decipher the respective roles of the wild-type versions of
Pdr1p and Pdr3p in the foundation of PDR in S. cerevisiae. We
showed that in comparison to that of the Pdr1p/Pdr3p pair, the
activity of Tac1p in C. albicans is much more focused and
probably involves other as yet undiscovered transcription fac-
tor(s).
MATERIALS AND METHODS
Strains, media, and growth conditions. All C. albicans and S. cerevisiae strains
used in this study were derived from SC5314 and BY4741, respectively. The
pdr1 and pdr3 strains were obtained from Euroscarf. The pdr1 pdr3 strain
is described in reference 20. Cells were grown in yeast extract-peptone-dextrose
at 30°C till the mid-log phase was reached (optical density at 600 nm [OD600] of
0.8 to 1.0) and then treated with progesterone (stock solution in ethanol; Sigma-
Aldrich) for two time points (30 min and 90 min) at three different concentra-
tions (109 M, 106 M, and 104 M). For studying the long-term effects of
steroids, progesterone (109 M, 106 M, or 104 M) was added to the medium
at the time of inoculation (inoculum OD600, 0.125) and cells were collected after
7 h of treatment (with the final OD600 remaining the same). For mock-treated
cells, the growth conditions were the same except that only ethanol was added in
the medium. The cells were harvested at room temperature in 50 ml centrifuge
tubes at 3,000 rpm for 3 min. Thereafter, the cells were washed once with sterile
milliQ water and snap-frozen in liquid nitrogen. The cell pellets were stored at
80°C.
RNA isolation, cDNA preparation, and microarray hybridization. Total RNAs
were isolated by breaking the cells with glass beads in a Fast-Prep FP120 cell
disrupter (Bio 101) at 4°C, followed by RNA purification on columns according
to the manufacturer’s protocol (RNAeasy minikit; Qiagen). The C. albicans
microarrays (batch C050G) were obtained from Eurogentec (Seraing, Belgium)
and contained cDNA probes, deposited in duplicates, for 98% of the Candida
Open Reading Frames (assembly 19). The S. cerevisiae microarrays were home-
made from the Operon collection of yeast open reading frame (ORF) oligonu-
cleotide probes (version 1.1.2), deposited in duplicate onto Corning ultragap
slides, using an Omnigrid II spotter from Biorobotics (Genomic Solutions). Each
experiment was done at least three times, with independent biological replicates
and using a dye swap. Fifteen micrograms of total RNA was resuspended in 20
l of RNase-free H20 along with 1 l of RNasin RNase inhibitor (Promega) and
then used for labeled cDNA synthesis. The direct-labeling protocol provided by
Eurogentec was used for C. albicans experiments. The S. cerevisiae cDNA label-
ing-and-hybridization protocol can be found at www.transcriptome.ens.fr/sgdb
/protocols/labelling_yeast.php.
cDNA microarray data analysis. Slides were read using a Genepix 4000B
scanner from Axon. The images were analyzed using the Genepix pro 6.0 soft-
ware. Data were normalized using the global “lowess” method followed by the
print-tip group median method from Goulphar (29). To get a list of statistically
significant genes (see Table S1 in the supplemental material), we combined the
two methods commonly in use in most microarray articles: we applied sequen-
tially a cutoff based on the gene expression variation (21) and a cutoff based on
the reproducibility of the measurement of this variation (38). More precisely, the
expression of gene i was considered significantly and reproducibly changed when
Mi was3 Sg and Mi/Si was2, where “Mi” is the average log2 value of change
measured for gene i, “Si” is the standard deviation observed for gene i, and “Sg”
is the standard deviation of the global distribution of the Mi values for all genes.
The P value (t test) associated with a gene satisfying both criteria is 0.001. The
complete microarray data set can be downloaded at www.biologie.ens.fr/lgmgml
/publication/albicans/. To address the biological relevance of the genes presented
in Table S1 in the supplemental material, we looked for gene functional cate-
gories, which were significantly enriched in these lists. Gene ontology searches
were performed by submitting the lists of genes in Table S1 in the supplemental
material to the Saccharomyces Genome Database and the Candida Genome
Database (CGD) GO (gene ontology) term finder tools (3, 4). The promoter
analyses were performed by submitting the whole set of microarray results to the
t-profiler tool (8), using default parameters. Homology links between S. cerevi-
siae and C. albicans were established using the CGD and the Saccharomyces
Genome Database. The S. cerevisiae protein sequences of interest were com-
pared to the CGD protein sequences using BLAST (3). A homology link was
created with the best hit when the corresponding P value was less than 1010.
When several C. albicans proteins had similar scores, we created multiple ho-
mology links (see Table S3 in the supplemental material) (see Fig. 5).
cDNA microarray data verification by Northern blotting and real-time PCR.
Twenty micrograms of total RNA was electrophoretically separated on denatur-
ing agarose gels and blotted onto Hybond N nylon membranes (Amersham
Biosciences). Probes used for hybridization were obtained by labeling gene
fragments obtained by PCR with [	-32P]dATP (Amersham Biosciences), using
specific primers on genomic DNA of strain SC5314 (C. albicans) or BY4741 (for
S. cerevisiae). For real-time PCR, CDR1 and CDR2 gene-specific primers were
designed and used along with the control ACT1 gene. Table S3 in the supple-
mental material lists all the primers used in this study. The probe for PDR5 was
prepared by digesting a part of the PDR5 gene from the plasmid (pDR3.3)
containing the PDR5 clone.
Microarray data accession numbers. The microarrays used in this work are
fully described in the ArrayExpress database (www.ebi.ac.uk/miamexpress/; ac-
cession numbers A-MEXP-337 [S. cerevisiae arrays] and A-MEXP-878 [C. albi-
cans arrays]). Raw and normalized data files have been deposited under acces-
sion number E-TABM-345.
RESULTS
Quantitative features of the steroid response in C. albicans
and S. cerevisiae. We analyzed the transcriptomes of wild-type
cells of both species treated with three different doses of pro-
gesterone (two supraphysiological doses, 104 and 106 M,
and one physiological dose, 109 M) for three different time
periods (30 min, 90 min, or 7 h). None of these doses affected
cell growth (data not shown). The corresponding cDNAs were
competitively hybridized on DNA microarrays versus cDNAs
obtained from mock-treated cells. We observed that for both
species, the number of genes whose expression changed signif-
icantly and reproducibly was maximal at the 104 M dose, with
only a few genes being induced by a 106 M treatment (Fig. 1).
Few significant and reproducible gene expression changes
could be detected for the physiological dose (see Table S1 in
the supplemental material). The steroid response was fast and
transient, peaking at 30 min for both species (Fig. 1). Only a
few genes remained induced or repressed up to 7 h of treat-
ment. The numbers of genes in C. albicans and S. cerevisiae
that changed expression in the presence of progesterone were
similar except after 30 min of the 104 M treatment, when the
C. albicans response involved about 10 times more genes than
that in S. cerevisiae (Fig. 1B). A gene ontology analysis indi-
cated that this was mainly due to the induction of genes in-
volved in the oxidative stress response, sulfur and glucose me-
tabolism, and proteasome activity and the repression of genes
involved in ribosome biogenesis and in translation (see Table
S1 in the supplemental material). This oxidative stress-like
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response in C. albicans was fast and transient and was not
observed at longer times or lower doses. To get a biologically
relevant view of the pathways which are preferentially sensitive
to progesterone, we looked for gene groups which were signif-
icantly enriched in the lists of significant gene expression vari-
ations (see Table S1 in the supplemental material). Note that
due to the high number of replicate measurements (six per
gene on average) and their high reproducibility, we were able
to point out as statistically significant gene expression varia-
tions as low as 0.3 (log2 value). Also, it is important to mention
that all the genes discussed in the rest of this article satisfied
three criteria: their expression variations were significantly dif-
ferent from the bulk of yeast genes (Mi cutoff), this Mi value
was reproducible over the six measurements which were per-
formed (S value criteria), and they belong to a gene category
which is significantly enriched in the lists of genes induced by
progesterone (see Methods). Moreover, the biological rele-
vance of many of the genes discussed below was supported by
Northern blot (see Fig. S2 in the supplemental material)
and/or further microarray analyses investigating the transcrip-
tional mechanisms underlying the progesterone response (see
Fig. 3 and Table 2). Finally, several of these genes showed
changed expression at several time points and doses. For all
these reasons, we have a very high level of confidence in the
biological and statistical relevance of the results discussed be-
low, even when Mi values were unusually low.
Progesterone activates PDR1/3 and ergosterol pathways in
S. cerevisiae. In S. cerevisiae, two pathways are mainly respon-
sible for pleiotropic drug resistance phenotypes: the PDR
pathway, controlled by the Pdr1p and Pdr3p transcription fac-
tors, and the ergosterol biosynthesis pathway (2). Gene ontol-
ogy and DNA regulatory motif mining of our microarray data
indicated that progesterone specifically and extensively acti-
vated these two pathways (see Table S1 in the supplemental
material) (Table 1). Four types of PDRE bound by Pdr1 and
Pdr3 have been described (16), named A (TCCGCGGA), B
(TCCGTGGA), C (TCCGCGCA), and D (TCCGCGGG).
PDRE A, B, and D were found to be significantly correlated
with progesterone induction at all time points of the supra-
physiological-dose treatments except at 7 h with a 106 M
concentration (Table 1). Half of the genes induced at 30 min
by 104 M progesterone are referenced as targets of Pdr1p and
Pdr3p (Fig. 1) (see Table S1 in the supplemental material).
These genes represent about 80% of the Pdr1p/Pdr3p targets
defined previously (1, 16, 17, 18, 20, 28), including genes en-
coding Pdr3p itself, the ABC transporters Pdr5p, Pdr15p,
Pdr10p, Yor1p, and Snq2p, the membrane phospholipid me-
tabolism and transport proteins Rsb1p, Pdr16p, and Rta1p, the
oxidoreductase Gre2p, etc.
At 90 min of the treatment with a 104 M concentration, the
PDR response was followed by the induction of genes involved
in ergosterol biosynthesis, which represent about 20% of the
genes induced at this time point (Fig. 1 and 2B) (see Table S1
in the supplemental material). As a consequence, ergosterol
metabolism was one of the main gene ontology categories to be
significantly enriched in the list of genes induced at 90 min and
7 h of the 104 M concentration treatment (see Table S1 in the
supplemental material). These genes (ERG25, ERG11, ERG5,
FIG. 1. Genome-wide responses of two yeast species to progesterone. The histograms represent the numbers of genes which were up- and
down-regulated in response to progesterone (results from Table S1 in the supplemental material), as a function of the dose of progesterone and
time of exposure to the steroid (x axis). Panels A and B present results for S. cerevisiae and C. albicans, respectively. The proportions of S. cerevisiae
genes referenced as targets of Pdr1p/Pdr3p and of C. albicans genes referenced as targets of Tac1p are shown in black. The proportions of genes
involved in steroid and ergosterol metabolic pathways are represented as dots.
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ERG4, ERG3, and ERG28) encode enzymes from the ERG
pathway. Interestingly, the UPC2 gene, encoding a transcrip-
tional activator of the ERG genes, although not reaching our
confidence limit, exhibited an expression profile similar to that
of the ERG genes (Fig. 2B). Moreover, the Upc2p DNA bind-
ing motif was significantly correlated with progesterone induc-
tion at 90 min of the 104 M treatment (Table 1). The PDR
and ERG pathways were very stably induced by progesterone,
since some of these genes were still induced after 7 h of treat-
ment, although their levels of induction tended to decrease
with time (Fig. 2A and B; Table 1).
Transcriptional regulation of the progesterone-induced
PDR response in S. cerevisiae. Considering the large set of
PDR genes which were activated by progesterone, we used
microarrays to analyze the effects of deletion of PDR1 and
PDR3 on the steroid-induced expression of genes belonging to
the PDR network (Fig. 3). The progesterone induction exper-
iments were done with the pdr1, pdr3, or pdr1 pdr3 strain
at time 30 min and with a dose of progesterone of 104 M,
which corresponded to the maximum PDR response in the
wild-type cells (Fig. 2A). We observed three different types of
gene expression profiles (Fig. 3A). Some genes (e.g., GRE2,
ICT1, YOR1, YPL088w, YLL056c, and PDR10) were exclu-
sively Pdr1p dependent (group I), whereas for other genes
(PDR16, RSB1, YGR035c, and YLR346c), the absence of
PDR1 could be partially complemented by Pdr3p (group II).
Finally, group III included genes (PDR5, PDR15, SNQ2, TPO1,
and YAL061w) which are sensitive only to the double deletion
and for which the absence of Pdr1p is fully complemented by
Pdr3p. Interestingly, we observed that as far as steroid stimu-
lation is concerned, the PDR3 induction is insensitive to the
PDR1 deletion (Fig. 3A). Even though the number of genes in
each group was low, we observed biases in the type and number
of PDRE present in each group, which may reflect some func-
tional differences in the binding affinities of Pdr1p and Pdr3p
(Fig. 3B). Indeed, the genes depending exclusively on Pdr1p
for steroid regulation contained a lower number of PDRE
(only one in most cases), which are only of the B type, in their
promoters. On the contrary, the promoters at which Pdr3p can
fully complement Pdr1p are among the richest in PDRE (2.4
per promoter on average) and almost always contain both the
A and B types (Fig. 3B). We verified some of these results by
using Northern blotting. The control genes have been chosen
so as to include genes from all three groups in Fig. 3. For
FIG. 2. Gene expression profiles of PDR (A) or ERG (B) S. cerevisiae genes in response to progesterone. The log2 values of S. cerevisiae gene
induction by progesterone are represented as a function of the dose and time of exposure to the steroid. The genes represented here are a selection
of PDR genes (A) or of genes involved in ergosterol biosynthesis (B), responding to progesterone. The gene expression profiles of ICT1, PDR16,
PDR5, and YAL061w were confirmed by Northern blot analyses.
TABLE 1. Known motifs overrepresented in genes up-regulated by
progesterone and identified by using t-profiler with
default parameters (8)
Organism Time point, dose,and motif
Name of motif
(types)
t
value
No.
of
ORFs
C. albicans 30 min, 106 M
TWCCCM MIG1 3.9 629
90 min, 104 M
TCTCC ADR1 3.71 1,600
CCCCAC Energy 3.58 370
7 h, 104 M
TATAWAW TBP 3.9 2,786
S. cerevisiae 30 min, 104 M
TCCGYGGA PDRE (A, B) 13.03 52
TCCGYGGR PDRE (A, B, D) 11.45 68
TCCGCGG PDRE (A, D) 7.82 60
TGACTCA GCN4 4.17 94
GGTGGCRA RPN4 4.12 84
30 min, 106 M
TCCGYGGA PDRE (A, B) 4.93 52
TCCGYGGR PDRE (A, B, D) 4.11 68
90 min, 104 M
TCCGYGGA PDRE (A, B) 6.83 52
TCCGYGGR PDRE (A, B, D) 6.2 68
TCGTTTA UPC2 5.72 208
TCCGCGG PDRE (A, D) 4.73 60
CGATGAG PAC 4.51 198
90 min, 106 M
CGATGAG PAC 4.9 198
TGACTCA GCN4 4.02 94
TCCGYGGA PDRE (A, B) 3.62 52
7 h, 104 M
TGACTCA GCN4 8.82 93
AAAATTT rRPE 5.39 1097
TCCGYGGA PDRE (A or B) 5.06 52
TCCGYGGR PDRE (A, B, D) 4.7 68
CCSGTANCGG Leu3 3.82 12
7 h, 106 M
TGACTCA GCN4 5.83 94
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example, ICT1 from group I, PDR16 from group II, and PDR5
and YAL061w from group III (see Fig. S2A and B in the
supplemental material).
The PDR response to steroids is only partly conserved in C.
albicans. Except for the 30-min time point with the 104 M
dose (see above), the C. albicans response to progesterone was
restricted to fewer than 60 different genes involved in arginine
metabolism, drug export, lipid and ergosterol metabolism, bio-
film formation (up-regulated), and iron and glucose transport
(down-regulated) see Table S1 in the supplemental material).
As observed for S. cerevisiae, PDR transporter-encoding genes
(namely, CDR1 and CDR2) were among the most highly and
FIG. 3. Analysis of the respective roles of Pdr1 and Pdr3 in the S. cerevisiae progesterone-induced PDR response. (A) Progesterone induction
of PDR genes in different genetic backgrounds. Microarrays were used to analyze the progesterone induction of genes in strains deleted for PDR1
and/or PDR3. The histograms represent the log2 values of the expression ratios observed between treated and untreated cells. The time and dose
of treatment were 30 min and 0.1 mM, respectively. Three clusters of genes (named groups I to III) were distinguished, depending on their gene
expression patterns. (B) Type and number of PDRE in the three groups of Pdr1/Pdr3 target genes. Four types of PDRE have been described (16)
and named A (TCCGCGGA), B (TCCGTGGA), C (TCCGCGCA), and D (TCCGCGGG). The histograms represent the number/promoter and
types of PDRE in each of the three groups of PDR genes defined from panel A.
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stably steroid-induced genes (Fig. 4) (see Fig. S1 in the sup-
plemental material). The CaCDR1 gene expression profile was
remarkably similar to the ScPDR5 expression profile, indicat-
ing that the mechanisms involved in progesterone induction of
these genes may be conserved from S. cerevisiae to C. albicans.
This is in spite of the fact that the promoters of the two genes
harbor different regulatory elements (discussed below). To get
a global qualitative and quantitative estimation of the conser-
vation of the PDR and ERG responses to progesterone in both
a nonpathogenic and pathogenic yeast species, we made two
independent hierarchical clusterings of the PDR and ERG
genes induced by progesterone in S. cerevisiae and of their
closest homologues in C. albicans. We then directly compared
the gene expression profiles of the homologous gene pairs
using Pearson correlation distances (Fig. 5) (see Table S2 in
the supplemental material). We observed various situations
depending on the gene categories. We found no conservation
of the ERG response, identified in S. cerevisiae and in C.
albicans. No conservation was observed for the expression pro-
files of most of the ERG genes (UPC2, ERG1, ERG5, ERG10,
ERG11, ERG12, ERG25, and ERG16), which were even re-
pressed at 30 min of a 104 M progesterone treatment (see
Table S1 in the supplemental material) (Fig. 5). In contrast, we
found full conservation of the induction of the oxidoreductases
(Gre2p-like)-encoding and putative flippase (Rsb1p-like)-en-
coding genes involved in the PDR response, with two homol-
ogous genes being similarly induced in both species (Fig. 5). In
the case of the ABC transporter family, we found a partial
conservation, with only two Candida genes (CDR1 and CDR2)
being sensitive to progesterone when four of their homologues
(PDR5, PDR15, PDR10, and SNQ2) were induced in S. cerevi-
siae.
Although about 20 Pdr1/Pdr3 target genes were induced in
S. cerevisiae, we could find only 9 homologues of these genes
being similarly regulated in C. albicans (see Table S1 in the
supplemental material) (Fig. 5). One simple explanation would
be that the PDR pathways in C. albicans involve genes which
are not clear homologues of the S. cerevisiae PDR genes but
which play similar functional roles. We found that this is the
case for the C. albicans PDR transcriptional regulator Tac1p,
which is not strictly homologous to S. cerevisiae Pdr3p but
which belongs to the same family of Gal4p-like transcription
factors and exhibited a similar expression profile in response to
progesterone (Fig. 2A and 4). Almost all known putative
Tac1p targets were induced by progesterone (Fig. 4). This
includes CDR1, CDR2 (encoding homologues of Pdr5p), RTA3
(encoding an orthologue of the putative S. cerevisiae flippase
Rsb1p) and IFU5 (Fig. 4). To get a more complete view of the
Tac1p role and of the C. albicans PDR network involved in the
steroid response, we compared the transcriptome of tac1 cells
treated for 30 min with 104 M progesterone to the transcrip-
tome of either parental cells or the revertant of the TAC1
knockout (11) with the same treatment. We observed a very
limited effect of TAC1 deletion on the progesterone response.
Only CDR1, CDR2, RTA3, HSP70, and MET15 exhibited sig-
nificantly reduced expression in the mutant strain (Table 2).
The involvement of Tac1p in the steroid-induced expression of
CDR1 and RTA3 was confirmed by Northern blotting experi-
ments (see Fig. S2C in the supplemental material).
DISCUSSION
Progesterone specifically induces a long-term PDR response
in pathogenic and nonpathogenic yeasts. Although it has been
established for a long time that human steroids affect yeast
growth, morphogenesis, and drug resistance, their molecular
action and signaling in fungi remain unresolved. Previous mi-
croarray experiments showed that an elevated dose (103 M)
of progesterone rapidly (30 min) and transiently induced a
large stress response in both S. cerevisiae and C. albicans (5, 6).
FIG. 4. Expression profiles of C. albicans potential targets of the Tac1p transcription factor. The log2 values of gene induction by progesterone
are represented as a function of the dose and time of exposure to progesterone. The genes represented here are the genes which have been defined
previously as potential Tac1p targets (11). The genes RTA3, TAC1, GDH3, and PDR16 were confirmed by Northern blotting, while CDR1 and
CDR2 were confirmed by quantitative real-time PCR.
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The response included an overexpression of genes involved in
the PDR phenomenon. In the present study, we analyzed the
C. albicans and S. cerevisiae responses to lower doses of pro-
gesterone (104 M to 109 M) for extended time periods (30
min to 7 h) and compared the transcriptional regulation of
PDR responses in these two species. We found that the steroid
response is more prominent at supraphysiological concentra-
tions and at shorter time points. In other words, the steroid
response is transient in nature, the yeast cells probably adapt to
the presence of steroids after continuous exposure at low
doses, and gene expression probably reaches an equilibrium
that is difficult to measure with physiological doses for rela-
tively short time periods. We observed that the PDR pathways
and especially the genes encoding the multidrug ABC trans-
porters Pdr5p in S. cerevisiae and Cdr1p in C. albicans were the
most sensitive to and stably induced by progesterone. This was
especially impressive with S. cerevisiae, in which almost 100%
of the genes induced by a 1 M, 7-h progesterone treatment
belong to the PDR pathway. The S. cerevisiae PDR network is
composed of at least 25 genes regulated by the Pdr1p and
Pdr3p transcription factors (34). Our experiments showed that
more than 80% of these genes responded to progesterone. For
FIG. 5. Comparative functional genomics of the PDR and ERG responses to progesterone. The ERG and PDR genes of S. cerevisiae were
clustered according to their expression profiles following progesterone treatment. A similar clustering was done for the C. albicans orthologues or
closest homologues of these genes. The homology links can be found in Table S2 in the supplemental material. Color coding indicates the main
PDR gene families in both species: blue, ABC transporters; red, oxidoreductases from the Gre2 family; brown, putative flippases from the RTA
family; gray, ICT1; green, putative aryl alcohol dehydrogenases; black, others. An arrow connects two homologues when the Pearson correlation
distance between their expression profiles is significantly low (d 
 0.4).
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comparison, only 40% of these genes are up-regulated by flu-
phenazine, which is known to induce PDR in both S. cerevisiae
and C. albicans (20, 23). This makes progesterone the most
efficient inducer of the PDR pathway in S. cerevisiae (see Fig.
S1 in the supplemental material).
For C. albicans, our knowledge of PDR regulation is more
limited than for S. cerevisiae. A major mechanism of PDR is
the up-regulation of multidrug transporters belonging to the
ABC (ATP-binding cassette) transporter family (e.g., CDR1
and CDR2), which is the equivalent of the PDR pathway of
budding yeast, or of the major facilitator family (e.g., MDR1),
which is the equivalent of the YAP1/FLR1 pathway in budding
yeast (11). Remarkably, progesterone induced almost all the
genes known to be coregulated with CDR1/CDR2 in C. albi-
cans. This included IFU5, RTA3, HSP70, HSP90, and TAC1.
This striking sensitivity of the PDR network to progesterone in
both species suggests that steroids act directly on the physio-
logical parameters which trigger the PDR response. In S. cer-
evisiae, the progesterone treatment strikingly mimicked the
gene expression profiles obtained from cells expressing “mini-
Pdr1p” or gain-of-function versions of Pdr1p in which the
whole Gal4-like inhibitory domain has been deleted or mu-
tated (17). One reasonable hypothesis would be that proges-
terone indirectly triggers an efficient deregulation of Pdr1p
through its inhibitory domains. Progesterone could act on the
PDR networks by directly modifying the activity and properties
of some PDR ABC transporters. Although it was shown that
progesterone is a good substrate of Pdr5p and Cdr1p (27), it is
unlikely that progesterone acts just by competing “natural”
Pdr5p or Cdr1p substrates for transport, for the following
reasons: (i) other good substrates of Pdr5p/Cdr1p, like flucon-
azole, are poor inducers of the PDR response (27), and (ii) low
(1 M) doses of progesterone are enough to trigger an efficient
PDR5/CDR1 induction. Recently estradiol derivatives were
shown to efficiently inhibit the drug transport and ATPase
activities of Pdr5p and Cdr1p (10). This suggests that human
steroids act directly on the activity of the PDR transporters
through a mechanism which is yet to be determined but which
has important and long-term implications for the activity of the
PDR transcriptional networks and thus the PDR status of yeast
strains. Noteworthy here is our finding that the steroid re-
sponse is more prominent at supraphysiological concentrations
and at shorter time periods. In other words, the steroid re-
sponse is transient in nature, the yeast cells probably adapt to
the presence of steroids after continuous exposure at low
doses, and gene expression probably reaches an equilibrium
that is hard to measure at low doses for short time periods.
It should be pointed out that in addition to PDR genes, we
found that the ergosterol biosynthetic pathway genes (ERG
genes) were also induced by progesterone. Of note, ERG
genes have often been found to be coregulated along with
CDR1 and CDR2 in both experimentally induced and azole-
resistant clinical isolates of C. albicans, and overexpression of
ERG genes, especially ERG11, is one of the predominant
mechanisms of multidrug resistance (MDR) in Candida (7, 22,
30, 39). Hence, the observed up-regulation of ERG genes
along with MDR genes in the presence of progesterone is
perhaps an indication of the adaptation of the cells to a drug
resistance phenotype. UPC2 is a transcription factor involved
in regulation of ergosterol biosynthesis genes and a regulator
of sterol uptake across the plasma membrane (37), which was
also upregulated by progesterone (present results). Addition-
ally, it is pertinent to mention that the efflux pump proteins,
such as Cdr1p, are selectively localized in ergosterol-rich mem-
brane microdomains (36), and an overexpression of Cdr1p may
necessitate up-regulation of ERG genes as a compensatory
sterol homeostasis mechanism (35).
New insights into functioning of yeast PDR transcriptional
networks. In S. cerevisiae, Pdr1p and Pdr3p share a very similar
set of target genes and recognize the same DNA consensus
sequence (PDRE) in their promoters (14, 16). The PDR3 gene
itself has been shown to be regulated by Pdr3p and Pdr1p (13)
and was sensitive to progesterone in our experiments. In this
study, we found that most of the PDR genes were insensitive to
progesterone in a pdr1 pdr3 strain. Remarkably, Pdr1p was
dispensable for the regulation of PDR3 under these conditions,
although it is constitutively bound to its promoter (20), sug-
gesting that the progesterone induction of PDR3 occurs
through autoregulation. We propose that progesterone can be
used as a tool to investigate the respective roles of the wild-
type versions of Pdr1p and Pdr3p in the PDR response. We
confirmed that PDR3 has a dispensable role in the response to
drugs. Based on their PDR3 dependency in a pdr1 back-
ground, we were able to distinguish between three different
groups of PDR targets. We found a correlation between these
groups and the nature and number of PDRE present in the
promoters of the corresponding genes, suggesting that the
DNA binding affinities of Pdr1p and Pdr3p may be different.
Interestingly, these groups also present biases in the function
of the proteins encoded by the corresponding genes. Pdr1p and
Pdr3p have identical activities on the genes encoding most of
the main transporters involved in pleiotropic drug export
(PDR5, PDR15, SNQ2, and TPO1). They have an overlapping
effect, with a dominant effect of Pdr1p on genes encoding
actors of lipid metabolism and some coregulated proteins of
unknown function (RSB1, PDR16, YGR035c, and YLR346c
genes), and Pdr1p specifically regulates genes which, in most
cases, are sensitive to other stress response pathways (GRE2,
YPL088w, YLL056c, ICT1, YOR1, and PDR10 genes). The
differential regulation of the PDR1/3 genes may reflect differ-
ences in their physiological roles and the functional associa-
tions of the corresponding proteins.
TABLE 2. Effect of TAC1 knockout on progesterone response
in C. albicans
ORF Name
Ratio of responses to progesteronea
Progesterone/
mock, WT
WT/Tac1KO,
progesterone
Tac1Rev/Tac1KO,
progesterone
CA6066 CDR1 3.85 1.68 1.98
CA6099 CDR2 3.31 2.28 2.26
CA2565 MET15 2.45 1.84 0.85
CA1230 HSP70 2.17 1.03 0.49
CA3606 RTA3 1.53 0.89 0.58
a The response of tac1 (Tac1KO) cells to a 30-min treatment with 0.1 mM
progesterone was compared to the responses of the parental (WT) (second
column) and Tac1-revertant (Tac1Rev) (third column) strains by using microar-
rays. The numbers are log2 values of expression ratios. Gene induction by
progesterone in the parental strain is indicated (first column). Only genes which
are involved in the progesterone response and which were significantly and
reproducibly differentially expressed in the tac1 strain are represented here.
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In C. albicans, Tac1p is the only clear regulator of the PDR
response identified to date (11). Tac1p belongs to the same
family of Gal4p-like transcription factors as Pdr1p and Pdr3p,
and we found that the progesterone induction profile of TAC1
was very similar to that of PDR3, although no evidence exists
for autoregulation of TAC1. Only six Tac1p target genes
(CDR1, CDR2, RTA3, IFU5, PDR16, and HSP12) have been
identified, and Tac1p has been shown to recognize the DRE
present in their promoters, which is different from the PDRE
of S. cerevisiae (11, 15). A deletion of TAC1 is enough to
decrease the basal level of expression of CDR1 and CDR2,
which is different from the situation for S. cerevisiae, in which
the double deletion of PDR1 and PDR3 is needed to observe
the same effect (11, 14). All these observations suggested that
progesterone would be a perfect model for exploring the
Tac1p-related transcriptional pathway. Surprisingly, only five
genes (CDR1, CDR2, RTA3, MET15, and HSP70) were depen-
dent on Tac1p for their progesterone induction. These results,
together with the very limited number of Tac1p targets iden-
tified from TAC1 gain-of-function alleles (11), strongly suggest
that the Tac1p effect is much more dedicated and focused than
that of the Pdr1p/Pdr3p network. This hypothesis is supported
by a recent genome-wide study of Tac1p genomic location and
activity, which identified about 37 genomic loci bound by
Tac1p, only 8 of which displayed Tac1p dependence for their
gene expression (31). It is noteworthy that the induction of the
Tac1p target IFU5 was insensitive to the deletion of TAC1.
This suggests that another, yet-unknown transcription factor(s)
may second Tac1p in the steroid response. Three suppressors
of the drug hypersensitivity of S. cerevisiae pdr1 pdr3 cells,
named SHY1 to -3, have been identified in C. albicans, with
apparently no role in the regulation of CDR1 and CDR2 (11)
but which are obvious candidates to be tested for their role in
steroid response. Additionally, ZNC1, which encodes a Tac1p
homologue and is located close to the TAC1 gene in the C.
albicans genome, is overexpressed by progesterone and could
have a role in drug response, although it has no apparent role
in CDR1/CDR2 basal expression (11).
Conserved and divergent features of PDR network in yeasts.
The high sensitivity of the PDR genes to progesterone in S.
cerevisiae and C. albicans led us to examine in detail the con-
servation of the transcriptional networks which drive the drug
response in these two hemiascomycetes species, which di-
verged several million years ago and have very distinct ecolog-
ical niches. In several cases (CaRTA3/ScRSB1, CaCDR1/
ScPDR5, and CaCDR2/ScPDR15), we observed a remarkable
similarity of expression profiles between the two yeast species.
The most impressive case was that of CaCDR1/ScPDR5, which
exhibited almost identical patterns. Of note, the cis elements
known to regulate the drug response of CDR1 (DRE) and
PDR5 (PDRE) are quite different (11, 15, 16). It is also worth
mentioning here that within the steroid-responsive region
found by Karnani et al. (26) in the CDR1 promoter, which
responds to both progesterone and -estradiol, three con-
sensus 5-bp stretches of nucleotides (AAGAA, CCGAA, and
ATTGG) exist, which has also been found in the PDR5 pro-
moter (5, 26). This may account for the commonality in expres-
sion patterns of CDR1 and PDR5.
On closer inspection, several differences also emerged be-
tween the responses of the two yeasts to progesterone. For
instance, the expression profiles of four ABC transporter
genes, PDR5, SNQ2, PDR10, and PDR15, in S. cerevisiae cor-
relate with the pattern of only two homologous genes, CDR1
and CDR2, in C. albicans, while CDR3 and CDR4 are appar-
ently insensitive to progesterone stimulation. In other cases,
the S. cerevisiae PDR genes just do not have clear homologues
in C. albicans. This is the case, for instance, for YGR035c and
YLR346c. Similarly, WWM1, the S. cerevisiae homologue of
CaIFU5 (one of the Tac1p targets responding to steroids), is
insensitive to progesterone and has no role in PDR.
Comparative genomics has been used in the past to identify
meaningful, conserved DNA or protein motifs from sequence
comparisons, and the interspecies comparison of transcrip-
tome data can be very informative in identifying conserved
transcriptional modules of genes likely to have common essen-
tial functions (25). In the case of yeast PDR, our comparison
of the Pdr1p/Pdr3p and Tac1p transcriptional networks sug-
gests that although the DNA binding motifs and the protein
sequences of these regulators have significantly diverged, there
must have been a strong selection to conserve the pattern of
regulation of at least two ABC transporters (CaCDR1/ScPDR5
and CaCDR2/ScPDR15) and one putative flippase (CaRTA3/
ScRSB1) (Fig. 6). This conserved module, which functions in
pleiotropic drug export and is also related to membrane phos-
pholipid translocation, may thus constitute a central, original
core of MDR in pathological and nonpathological hemiasco-
mycetes species.
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